{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Merck &amp; Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.", "headline": {"main": "Merck: New Drugs Pending Approval or in Late Tests", "print_headline": "Merck: New Drugs Pending Approval or in Late Tests"}, "abstract": null, "print_page": null, "word_count": "543", "_id": "53693ff77988100a9d78006a", "snippet": "Merck &amp; Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/05/06/business/ap-us-merck-outlook.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-05-06T16:01:33Z", "section_name": "Business Day"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "The American Orthotic and Prosthetic Association finds fault with a study questioning the value of cranial helmets.", "headline": {"main": "Study of Helmet Therapy", "kicker": "Letter", "print_headline": "Study of Helmet Therapy", "content_kicker": "Letter"}, "abstract": null, "print_page": "24", "word_count": "228", "_id": "5368160d7988101f6178f124", "snippet": "The American Orthotic and Prosthetic Association finds fault with a study questioning the value of cranial helmets.", "source": "", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/05/06/opinion/study-of-helmet-therapy.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Physical Therapy", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Helmets", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "3", "name": "subject"}], "byline": [], "document_type": "article", "pub_date": "2014-05-06T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "Vatican Dialogue: 'Man is a Technical Giant and an Ethical Child'", "kicker": "Dot Earth"}, "abstract": "At the Pope\u2019s science academy, an unfolding discussion of the role of science and ethics in shaping the human journey.", "print_page": null, "word_count": "909", "_id": "53642fd279881074d5bff14a", "snippet": "At the Pope\u2019s science academy, an unfolding discussion of the role of science and ethics in shaping the human journey.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://dotearth.blogs.nytimes.com/2014/05/02/vatican-dialogue-man-is-a-technical-giant-and-an-ethical-child/", "multimedia": [{"subtype": "wide", "url": "images/2014/05/03/blogs/dotvatican1/dotvatican1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/03/blogs/dotvatican1/dotvatican1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/03/blogs/dotvatican1/dotvatican1-articleLarge.jpg", "height": 450, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/03/blogs/dotvatican1/dotvatican1-articleLarge.jpg", "xlargeheight": "450"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/03/blogs/dotvatican1/dotvatican1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/03/blogs/dotvatican1/dotvatican1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Francis", "name": "persons", "rank": "1"}, {"value": "Rodriguez Maradiaga, Oscar", "name": "persons", "rank": "2"}, {"value": "Sachs, Jeffrey D", "name": "persons", "rank": "3"}, {"value": "Earth Institute (Columbia University)", "name": "organizations", "rank": "2"}, {"value": "Roman Catholic Church", "name": "organizations", "rank": "3"}, {"value": "United Nations", "name": "organizations", "rank": "4"}, {"value": "Columbia University", "name": "organizations", "rank": "1"}, {"value": "Millennium Development Goals", "name": "subject", "rank": "3"}, {"value": "International Relations", "name": "subject", "rank": "2"}, {"value": "Science and Technology", "name": "subject", "rank": "5"}, {"value": "Population", "name": "subject", "rank": "4"}, {"value": "Sustainable Living", "name": "subject", "rank": "7"}, {"value": "Sociology", "name": "subject", "rank": "6"}, {"value": "Birth Control and Family Planning", "name": "subject", "rank": "1"}], "byline": {"person": [{"firstname": "Andrew", "middlename": "C.", "lastname": "REVKIN", "rank": 1, "role": "reported", "organization": ""}], "original": "By ANDREW C. REVKIN"}, "document_type": "blogpost", "pub_date": "2014-05-02T19:51:33Z", "section_name": "Opinion"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Think Like a Doctor: 18-Year Rash Solved!", "kicker": "Well"}, "abstract": "Readers solve the case of a 40-year-old woman with a rash on her hands that persisted for nearly two decades.", "print_page": null, "word_count": "1476", "_id": "5363f97179881074d5bff0a9", "snippet": "Readers solve the case of a 40-year-old woman with a rash on her hands that persisted for nearly two decades.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2014/05/02/think-like-a-doctor-18-year-rash-solved/", "multimedia": [{"subtype": "wide", "url": "images/2012/02/29/health/29well_diagnosis/29well_diagnosis-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2012/02/29/health/29well_diagnosis/29well_diagnosis-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/02/29/health/29well_diagnosis/29well_diagnosis-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/02/29/health/29well_diagnosis/29well_diagnosis-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "name": "subject", "rank": "3"}, {"value": "Hands", "name": "subject", "rank": "2"}, {"value": "Sunlight", "name": "subject", "rank": "5"}, {"value": "Skin", "name": "subject", "rank": "4"}, {"value": "Allergies", "name": "subject", "rank": "1"}, {"value": "Ultraviolet Light", "name": "subject", "rank": "6"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Lisa", "lastname": "SANDERS", "rank": 1, "role": "reported", "organization": ""}], "original": "By LISA SANDERS, M.D"}, "document_type": "blogpost", "pub_date": "2014-05-02T15:59:18Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "", "headline": {"main": "Professional Pompom Problems", "kicker": "Room For Debate"}, "abstract": "How can cheerleaders keep their competitive edge as they enter the working world?", "print_page": null, "word_count": "2052", "_id": "5362f41279881006200b5077", "snippet": "How can cheerleaders keep their competitive edge as they enter the working world?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/roomfordebate/2014/05/01/professional-cheerleaders-and-their-pompom-problems/", "multimedia": [], "subsection_name": "Room For Debate", "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2014-05-01T18:45:22Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "In Pfizer's $100 billion (59.21 billion pounds) battle to win British drugmaker AstraZeneca, business and politics meet in a grassy field on the edge of the historic university city of Cambridge.", "headline": {"main": "In $100 Billion Astra Pfizer Fight, R&D Site Marks Political Frontline", "print_headline": "In $100 Billion Astra Pfizer Fight, R&D Site Marks Political Frontline"}, "abstract": null, "print_page": null, "word_count": "1002", "_id": "536263777988101129cd752d", "snippet": "In Pfizer's $100 billion (59.21 billion pounds) battle to win British drugmaker AstraZeneca, business and politics meet in a grassy field on the edge of the historic university city of Cambridge.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/05/01/business/01reuters-astrazeneca-pfizer-r-d.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-05-01T11:05:27Z", "section_name": "Business Day"}], "meta": {"hits": 6, "offset": 0, "time": 59}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}